191 related articles for article (PubMed ID: 27496194)
1. Murine Flt3 ligand-generated plasmacytoid and conventional dendritic cells display functional differentiation in activation, inflammation, and antigen presentation during BCG infection in vitro.
Meng C; Wang X; Xu Z; Hu M; Liu J; Pan Z; Chen X; Jiao X
In Vitro Cell Dev Biol Anim; 2017 Jan; 53(1):67-76. PubMed ID: 27496194
[TBL] [Abstract][Full Text] [Related]
2. Fms-like tyrosine kinase-3 ligand increases resistance to burn wound infection through effects on plasmacytoid dendritic cells.
Bae L; Bohannon JK; Cui W; Vinish M; Toliver-Kinsky T
BMC Immunol; 2017 Feb; 18(1):9. PubMed ID: 28228109
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-SCF.
Daro E; Butz E; Smith J; Teepe M; Maliszewski CR; McKenna HJ
Cytokine; 2002 Feb; 17(3):119-30. PubMed ID: 11895330
[TBL] [Abstract][Full Text] [Related]
4. Rapid loss of early antigen-presenting activity of lymph node dendritic cells against Ag85A protein following Mycobacterium bovis BCG infection.
Xu Z; Xia A; Li X; Zhu Z; Shen Y; Jin S; Lan T; Xie Y; Wu H; Meng C; Sun L; Yin Y; Chen X; Jiao X
BMC Immunol; 2018 Jun; 19(1):19. PubMed ID: 29940854
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 9 contributes to recognition of Mycobacterium bovis Bacillus Calmette-Guérin by Flt3-ligand generated dendritic cells.
von Meyenn F; Schaefer M; Weighardt H; Bauer S; Kirschning CJ; Wagner H; Sparwasser T
Immunobiology; 2006; 211(6-8):557-65. PubMed ID: 16920494
[TBL] [Abstract][Full Text] [Related]
6. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
Harada S; Kimura T; Fujiki H; Nakagawa H; Ueda Y; Itoh T; Yamagishi H; Sonoda Y
Int J Oncol; 2007 Jun; 30(6):1461-8. PubMed ID: 17487367
[TBL] [Abstract][Full Text] [Related]
7. Enhanced antigen-presenting activity and tumour necrosis factor-alpha-independent activation of dendritic cells following treatment with Mycobacterium bovis bacillus Calmette-Guérin.
Kim KD; Lee HG; Kim JK; Park SN; Choe IS; Choe YK; Kim SJ; Lee E; Lim JS
Immunology; 1999 Aug; 97(4):626-33. PubMed ID: 10457216
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium bovis BCG and purified protein derivative-induced reduction in the CD80 expression and the antigen up-take function of dendritic cells from patients with cervical cancer.
Manickam A; Sivanandham M
Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):413-7. PubMed ID: 21824715
[TBL] [Abstract][Full Text] [Related]
9. Flt3 ligand-generated murine plasmacytoid and conventional dendritic cells differ in their capacity to prime naive CD8 T cells and to generate memory cells in vivo.
Angelov GS; Tomkowiak M; Marçais A; Leverrier Y; Marvel J
J Immunol; 2005 Jul; 175(1):189-95. PubMed ID: 15972647
[TBL] [Abstract][Full Text] [Related]
10. Differential Effects of Mycobacterium bovis BCG on Macrophages and Dendritic Cells from Murine Spleen.
Xu Z; Meng C; Qiang B; Gu H; Sun L; Yin Y; Pan Z; Chen X; Jiao X
Int J Mol Sci; 2015 Oct; 16(10):24127-38. PubMed ID: 26473844
[TBL] [Abstract][Full Text] [Related]
11. M-CSF: a novel plasmacytoid and conventional dendritic cell poietin.
Fancke B; Suter M; Hochrein H; O'Keeffe M
Blood; 2008 Jan; 111(1):150-9. PubMed ID: 17916748
[TBL] [Abstract][Full Text] [Related]
12. Combined TLR stimulation with Pam3Cys and Poly I: C enhances Flt3-ligand dendritic cell activation for tumor immunotherapy.
Lim SN; Kuhn S; Hyde E; Ronchese F
J Immunother; 2012; 35(9):670-9. PubMed ID: 23090076
[TBL] [Abstract][Full Text] [Related]
13. Efficient Generation of Plasmacytoid Dendritic Cell from Common Lymphoid Progenitors by Flt3 Ligand.
Chen YL; Chang S; Chen TT; Lee CK
PLoS One; 2015; 10(8):e0135217. PubMed ID: 26263178
[TBL] [Abstract][Full Text] [Related]
14. Enhanced activation of T lymphocytes by urease-deficient recombinant bacillus Calmette-Guérin producing heat shock protein 70-major membrane protein-II fusion protein.
Mukai T; Maeda Y; Tamura T; Matsuoka M; Tsukamoto Y; Makino M
J Immunol; 2010 Nov; 185(10):6234-43. PubMed ID: 20935209
[TBL] [Abstract][Full Text] [Related]
15. Rat bone marrow-derived dendritic cells generated with GM-CSF/IL-4 or FLT3L exhibit distinct phenotypical and functional characteristics.
N'diaye M; Warnecke A; Flytzani S; Abdelmagid N; Ruhrmann S; Olsson T; Jagodic M; Harris RA; Guerreiro-Cacais AO
J Leukoc Biol; 2016 Mar; 99(3):437-46. PubMed ID: 26516183
[TBL] [Abstract][Full Text] [Related]
16. Selective expansion of perforin-positive CD8+ T cells by immature dendritic cells infected with live Bacillus Calmette-Guérin mycobacteria.
Tsunetsugu-Yokota Y; Tamura H; Tachibana M; Ogata K; Honda M; Takemori T
J Leukoc Biol; 2002 Jul; 72(1):115-24. PubMed ID: 12101270
[TBL] [Abstract][Full Text] [Related]
17. Impaired generation of reactive oxygen species during differentiation of dendritic cells (DCs) by Mycobacterium tuberculosis secretory antigen (MTSA) and subsequent activation of MTSA-DCs by mycobacteria results in increased intracellular survival.
Sinha A; Singh A; Satchidanandam V; Natarajan K
J Immunol; 2006 Jul; 177(1):468-78. PubMed ID: 16785544
[TBL] [Abstract][Full Text] [Related]
18. Discrepancy in Response of Mouse Dendritic Cells against BCG: Weak Immune Effects of Plasmacytoid Dendritic Cells Compared to Classical Dendritic Cells despite the Uptake of Bacilli.
Meng C; Liu J; Kang X; Xu Z; Xu S; Li X; Pan Z; Chen X; Jiao X
Trop Med Infect Dis; 2023 Feb; 8(3):. PubMed ID: 36977141
[TBL] [Abstract][Full Text] [Related]
19. The Balance between Conventional DCs and Plasmacytoid DCs Is Pivotal for Immunological Tolerance during Pregnancy in the Mouse.
Fang WN; Shi M; Meng CY; Li DD; Peng JP
Sci Rep; 2016 May; 6():26984. PubMed ID: 27229324
[TBL] [Abstract][Full Text] [Related]
20. Aqueous extract of Phyllanthus niruri (Euphorbiaceae) enhances the phenotypic and functional maturation of bone marrow-derived dendritic cells and their antigen-presentation function.
Nworu CS; Akah PA; Okoye FB; Esimone CO
Immunopharmacol Immunotoxicol; 2010 Sep; 32(3):393-401. PubMed ID: 20095802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
